Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
266,434,249
-
Total 13F shares
-
153,070,144
-
Share change
-
+4,162,225
-
Total reported value
-
$636,844,420
-
Put/Call ratio
-
79%
-
Price per share
-
$4.16
-
Number of holders
-
154
-
Value change
-
+$15,469,267
-
Number of buys
-
71
-
Number of sells
-
68
Institutional Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) as of Q3 2024
As of 30 Sep 2024 Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) had 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 153,070,144 shares of stock of the company.
Largest 10 holders included FMR LLC, Flagship Pioneering Inc., VANGUARD GROUP INC, BlackRock, Inc., BAILLIE GIFFORD & CO, CANADA PENSION PLAN INVESTMENT BOARD, STATE STREET CORP, Capital World Investors, GEODE CAPITAL MANAGEMENT, LLC, and Crestline Management, LP.
This table shows 150 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.